Research Analysis
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Oct 2024) | Next Qtr. (Jan 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 37 | 37 | 44 | 43 |
| Avg. Estimate | 0.74 | 0.8 | 2.84 | 4.02 |
| Low Estimate | 0.72 | 0.72 | 2.74 | 3.5 |
| High Estimate | 0.8 | 0.98 | 3.04 | 5.1 |
| Year Ago EPS | 0.37 | 0.47 | 1.19 | 2.84 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Oct 2024) | Next Qtr. (Jan 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 39 | 39 | 52 | 52 |
| Avg. Estimate | 32.86B | 36.45B | 125.5B | 178.25B |
| Low Estimate | 32.07B | 33B | 121.59B | 139.4B |
| High Estimate | 34.98B | 43.94B | 134.28B | 223.22B |
| Year Ago Sales | -- | 22.1B | 55.71B | 125.5B |
| Sales Growth (year/est) | -- | 64.90% | 125.30% | 42.00% |
Earnings History
| CURRENCY IN USD | 10/31/2023 | 1/31/2024 | 4/30/2024 | 7/31/2024 |
|---|---|---|---|---|
| EPS Est. | 0.31 | 0.42 | 0.51 | 0.64 |
| EPS Actual | 0.37 | 0.47 | 0.56 | 0.68 |
| Difference | 0.06 | 0.05 | 0.05 | 0.04 |
| Surprise % | 19.40% | 11.90% | 9.80% | 6.30% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Oct 2024) | Next Qtr. (Jan 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0.74 | 0.8 | 2.84 | 4.02 |
| 7 Days Ago | 0.74 | 0.81 | 2.84 | 4.02 |
| 30 Days Ago | 0.67 | 0.73 | 2.55 | 3.62 |
| 60 Days Ago | 0.64 | 0.71 | 2.49 | 3.43 |
| 90 Days Ago | 0.7 | 0.77 | 2.71 | 3.64 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Oct 2024) | Next Qtr. (Jan 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | 2 | 1 | 1 | 2 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | 1 | 1 | -- | -- |
Growth Estimates
| CURRENCY IN USD | NVDA | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 100.00% | -- | -- | 5.20% |
| Next Qtr. | 70.20% | -- | -- | 9.30% |
| Current Year | 138.70% | -- | -- | 3.10% |
| Next Year | 41.50% | -- | -- | 12.70% |
| Next 5 Years (per annum) | 52.53% | -- | -- | 11.91% |
| Past 5 Years (per annum) | 66.59% | -- | -- | -- |
Top AnalystsYahoo Finance’s Top Analysts section provides an objective scorecard to evaluate the accuracy of Wall Street analyst ratings and price targets.
Learn More
Yahoo Finance’s Top Analysts section provides an objective scorecard to evaluate the accuracy of Wall Street analyst ratings and price targets.
Learn MoreAnalyst | Overall Score | Direction Score | Price Score | Latest Rating | Price Target | Date |
|---|---|---|---|---|---|---|
| Wolfe Research | 90 | 85 | 96 | Outperform | 125 | 5/24/2024 |
| HSBC | 87 | 81 | 96 | Buy | 145 | 8/21/2024 |
| Rosenblatt | 86 | 84 | 94 | Buy | 200 | 8/30/2024 |
| Bernstein | 83 | 77 | 93 | Outperform | 155 | 8/29/2024 |
| Evercore ISI Group | 82 | 72 | 93 | Outperform | 150 | 8/24/2024 |
| Piper Sandler | 82 | 75 | 94 | Overweight | 140 | 8/29/2024 |
| Cantor Fitzgerald | 82 | 74 | 94 | Overweight | 175 | 8/29/2024 |
| Oppenheimer | 79 | 75 | 82 | Outperform | 110 | 5/24/2024 |
| B of A Securities | 79 | 70 | 93 | Buy | 165 | 9/5/2024 |
| UBS | 79 | 68 | 93 | Buy | 150 | 7/9/2024 |
Upgrades & Downgrades
| Initiated | William Blair: Outperform | 9/18/2024 |
| Reiterates | B of A Securities: Buy to Buy | 9/5/2024 |
| Maintains | Bernstein: Outperform to Outperform | 8/29/2024 |
| Maintains | Piper Sandler: Overweight to Overweight | 8/29/2024 |
| Reiterates | Wedbush: Outperform to Outperform | 8/29/2024 |
| Reiterates | Cantor Fitzgerald: Overweight to Overweight | 8/29/2024 |